Loading...
OTC Markets
Totals
Securities
12,214
Dollar Vol
$2.7B
Share Vol
3.1B
Trades
358,241

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

DGNOF
Diagnos Inc.

Ordinary Shares

0.164

0.00768

4.91%

0.16 / 0.164 (11006 x 8500)

Real-Time Best Bid & Ask: 05:00pm 07/18/2025
Delayed (15 Min) Trade Data: 12:00am 07/18/2025

Diagnos Inc.

7005 Taschereau Boulevard

Suite 265

Brossard, QC J4Z 1A7

Canada

Business Description
DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems through the use of its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications such as CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC). CARA image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for screening large numbers of patients in real-time.
Financial Reporting
Reporting Status
International Reporting: TSX Venture Exchange
Audited Financials
Audited
Fiscal Year End
3/31
Company Officers & Contacts
Andre Larente
President

Mr. Larente has been active in the information technology sector for more than 26 years. He has previously held leading management positions with companies such as Siemens, Syscan International, Newbridge Networks, Legent Corporation, Cognos, Tandem Computers and Honeywell Information Systems. His extensive business contacts and experience in the information technology sector, have enabled him to position DIAGNOS for rapid growth.

Yves-Stephane Couture
COO

Sales professional with two decades of experience in IT and telecommunication. Mr. Couture is bringing key strategic expertise from leading market innovator such as Teleglobe, Newbridge, Alcatel-Lucent and Nokia. During his career, he led teams to sell and implement complex infrastructure solution in health care provider and hospitals while bringing double digit growth in revenue for this vertical market. His experience, leadership and business acumen will contribute to the rapid growth of Diagnos.

Marc-Andre Massue
CFO

Mr. Massue joined the team in May 2008. He has more than 15 years of financial and human resources management experience, acquired mainly with technology companies. Mr. Massue's main responsibilities include the preparation of the annual and quarterly reports, the preparation of investment tax credits claims and the development and monitoring of internal management policies. Mr. Massue received a Bachelor in Business Administration (BBA) from HEC Montreal, and a Diploma in Economics from the Universite de Montreal. Mr. Massue is a member of the Quebec Order of Chartered Accountants.

Cindy Mercier
Contact Person

Board of Directors
Michael Braeuel
Independent Director

Michael has a successful track record as an accomplished entrepreneur with over 30 years of hands-on business experience. Over the years, he has been able to establish, expand, and ultimately sell two highly profitable businesses. One of them is providing engineering and systems integration services for machine vision inspection technology. He holds a master degree in engineering.

Philippe Couillard
Independent Director

Seasoned business advisor, neurosurgeon and former university professor, Dr. Couillard served as Premier of the province of Quebec from 2014 to 2018. Between 2003 and 2008, he was the province of Quebec's Minister of Health and Social Services. Today, Dr. Couillard acts as strategic advisor to Canadian and international organizations.

Robert William Alexander Dunn
Independent Director

Andre Larente
Audit Committee Member

Mr. Larente has been active in the information technology sector for more than 26 years. He has previously held leading management positions with companies such as Siemens, Syscan International, Newbridge Networks, Legent Corporation, Cognos, Tandem Computers and Honeywell Information Systems. His extensive business contacts and experience in the information technology sector, have enabled him to position DIAGNOS for rapid growth.

Other Company Insiders
Tristram Coffin
Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Raymond Chabot Grant Thornton

600, due De La Guachetiere Quest,

bureau 2000

Montreal, QC H3B 4L8

Canada

Securities Counsel
Borden Ladner Gervals LLP

40 King Street W

Toronto, ON M5H 3Y4

Canada

Profile Data
SIC - Industry Classification
7379 - Computer related services, misc
Incorporation Information
QC, CA, 1996
Employees
15 as of 01/31/2025
Shell
No
Products and Services

DIAGNOS markets CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care. CARA’s image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible.

Company Facilities

Head office

OTCQB Venture Market Logo
Joined OTCQB 06/2017
The Company Profile data was verified by the issuer within the previous 6 months.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.